ISPOR Recognizes Its Volunteer Leaders During National Volunteer Week

Published Apr 25, 2017
ANNOUNCEMENT Princeton, NJ—April 25, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) celebrates  the remarkable commitment and contribution of its volunteer leaders during National Volunteer Week.We make a living by what we get, but we make a life by what we give.” This quote by Winston Churchill (the British statesman) applies to each of ISPOR’s volunteer leaders. All the dedicated volunteer leaders at ISPOR embody this statement, and without their many contributions ISPOR would cease to exist. It is only through ISPOR’s volunteer leadership that the Society is able to fulfill its mission to promote health economics and outcomes research excellence (HEOR) to improve decision making for health globally. As those in the United States celebrate National Volunteer Week, ISPOR offers a heartfelt “thank you” to each of its volunteer leaders around the world. Every day ISPOR volunteers contribute to the Society’s mission to improve health care decisions by promoting HEOR excellence. Their work matters, their work advances the science within the HEOR community, and their work makes a very real difference in health care around the world.

###

  ABOUT ISPOR The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that promotes health economics and outcomes research excellence to improve decision making for health globally. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: http://bit.ly/ISPOR-T (@ISPORorg) | YouTube: http://bit.ly/ISPOR-YT | Facebook: http://bit.ly/ISPOR-FB

Related Stories

The Ozempic Paradox: How Spending Billions on Weight-Loss Drug Would Actually Reduce Overall Medicare Costs

Oct 14, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. The report, “Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare,” was published in the October 2025 issue of Value in Health.

ISPOR Europe 2025 Plenaries and Speakers Announced

Oct 13, 2025

ISPOR announced details for its ISPOR Europe 2025. The conference is the leading global conference in Europe for health economics and outcomes research (HEOR) and is scheduled for 9-12 November in Glasglow, Scotland, UK with the theme, “Powering Value and Access Through Patient-Centered Collaboration.”

ISPOR Launches New Content on Whole Health

Sep 23, 2025

ISPOR announced that it has launched new website content on whole health, a topic of increasing importance as health systems across the globe grapple with providing the best possible healthcare to patients within constrained budgets.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×